GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 120 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,245,000 | -36.2% | 86,180 | +1.8% | 0.00% | -50.0% |
| Q3 2016 | $1,951,000 | +67.2% | 84,648 | +20.4% | 0.00% | +100.0% |
| Q2 2016 | $1,167,000 | +208.7% | 70,327 | +195.0% | 0.00% | – |
| Q1 2016 | $378,000 | -50.0% | 23,841 | +2.0% | 0.00% | -100.0% |
| Q4 2015 | $756,000 | -48.9% | 23,373 | -33.4% | 0.00% | -50.0% |
| Q3 2015 | $1,480,000 | – | 35,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 383,702 | $14,581,000 | 7.71% |
| Perceptive Advisors | 5,148,910 | $195,658,000 | 5.23% |
| Grace Capital | 312,514 | $11,876,000 | 4.65% |
| NEXTHERA CAPITAL LP | 549,231 | $20,871,000 | 4.00% |
| Asymmetry Capital Management, L.P. | 103,449 | $3,931,000 | 3.63% |
| Camber Capital Management LP | 2,075,000 | $78,850,000 | 3.37% |
| Casdin Capital, LLC | 440,000 | $16,720,000 | 2.03% |
| EMORY UNIVERSITY | 53,951 | $2,050,000 | 1.34% |
| ArchPoint Investors | 129,435 | $4,919,000 | 1.34% |
| Ghost Tree Capital, LLC | 150,000 | $5,700,000 | 1.21% |